5696-79-7 Usage
General Description
(1-Naphthylmethyl)guanidine is an organic compound that belongs to the guanidine family of chemicals. It is a white crystalline solid and is commonly used as a reagent in organic synthesis. (1-NAPHTHYLMETHYL)GUANIDINE has been found to have various biological activities, including anti-inflammatory and neuroprotective properties. It is also used as a building block in the synthesis of pharmaceutically active compounds. The chemical structure of (1-naphthylmethyl)guanidine contains a guanidine functional group, which is known for its ability to form strong hydrogen bonds, making it a useful compound in various chemical reactions and applications. Overall, (1-naphthylmethyl)guanidine is a versatile and important chemical with several potential uses in the fields of medicine and organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 5696-79-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,6,9 and 6 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 5696-79:
(6*5)+(5*6)+(4*9)+(3*6)+(2*7)+(1*9)=137
137 % 10 = 7
So 5696-79-7 is a valid CAS Registry Number.
5696-79-7Relevant articles and documents
NON-PEPTIDIC INHIBITORS OF AKAP/PKA INTERACTION
-
Page/Page column 135; 209, (2008/06/13)
The invention relates to non-peptidic molecules which modulate, especially inhibit, the interaction of protein kinase A (PKA) and A kinase anchor proteins (AKAP) and to a host or target organism that comprises said non-peptidic compounds or recognition molecules directed to said compounds, such as e.g. antibodies or chelating agents. The invention also relates to a pharmaceutical agent, especially for use in the treatment of diseases that are associated with a disturbance of the cAMP signal path, especially insipid diabetes, hypertonia, pancreatic diabetes, duodenal ulcer, asthma, heart failure, obesity, AIDS, edema, hepatic cirrhosis, schizophrenia and others. The invention also relates to the use of the inventive molecules.
